Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Choroidal detachment following the use of tamsulosin (Flomax).

Shapiro BL, Petrovic V, Lee SE, Flach A, McCaffery S, O'Brien JM.

Am J Ophthalmol. 2007 Feb;143(2):351-3. Epub 2006 Oct 23.

PMID:
17258532
2.
3.
4.

Association between tamsulosin and intraoperative "floppy-iris" syndrome.

Leibovici D, Bar-Kana Y, Zadok D, Lindner A.

Isr Med Assoc J. 2009 Jan;11(1):45-9. Review.

7.

[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists].

Muramatsu I, Suzuki F, Tanaka T, Yamamoto H, Morishima S.

Yakugaku Zasshi. 2006 Mar;126 Spec no.:187-98. Review. Japanese.

8.

Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses.

Nargund VH, Grey AD.

Expert Opin Pharmacother. 2008 Apr;9(5):813-24. doi: 10.1517/14656566.9.5.813. Review.

PMID:
18345957
9.

[Floppy iris syndrome].

Dragomir L.

Oftalmologia. 2008;52(2):6-10. Review. Romanian.

PMID:
19065907
10.

ASCRS White Paper: clinical review of intraoperative floppy-iris syndrome.

Chang DF, Braga-Mele R, Mamalis N, Masket S, Miller KM, Nichamin LD, Packard RB, Packer M; ASCRS Cataract Clinical Committee.

J Cataract Refract Surg. 2008 Dec;34(12):2153-62. doi: 10.1016/j.jcrs.2008.08.031. Review.

PMID:
19027575
11.

Tamsulosin: current clinical experience.

O'Leary MP.

Urology. 2001 Dec;58(6 Suppl 1):42-8; discussion 48. Review.

PMID:
11750250
12.
13.

Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia.

Kawabe K.

Br J Urol. 1995 Jul;76 Suppl 1:63-7. Review. No abstract available.

PMID:
7544217
14.

Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Schulman CC.

Expert Opin Drug Metab Toxicol. 2008 Jun;4(6):771-82. doi: 10.1517/17425255.4.6.771 . Review. Erratum in: Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1581.

PMID:
18611117
15.
16.

OTC tamsulosin for benign prostatic hyperplasia.

[No authors listed]

Drug Ther Bull. 2010 Oct;48(10):113-6. doi: 10.1136/dtb.2010.10.0052. Review.

PMID:
20926447
17.

Intraoperative floppy iris syndrome associated with alpha1-adrenergic receptor antagonists.

Cantrell MA, Bream-Rouwenhorst HR, Steffensmeier A, Hemerson P, Rogers M, Stamper B.

Ann Pharmacother. 2008 Apr;42(4):558-63. doi: 10.1345/aph.1K679. Epub 2008 Mar 25. Review.

PMID:
18364408
18.

[Latest frontiers in pharmacotherapy for benign prostatic hyperplasia].

Kawabe K.

Yakugaku Zasshi. 2006 Mar;126 Spec no.:199-206. Review. Japanese.

20.

WITHDRAWN: Tamsulosin for benign prostatic hyperplasia.

Wilt TJ, Macdonald R, Rutks I.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD002081. doi: 10.1002/14651858.CD002081.pub2. Review.

PMID:
21901681

Supplemental Content

Support Center